STOCK TITAN

BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026

BillionToOne (NASDAQ: BLLN) announced it will report fourth quarter and full year 2025 financial results after market close on March 4, 2026.

(Neutral)
(Neutral)
Tags
earnings date

BillionToOne (NASDAQ: BLLN) announced it will report fourth quarter and full year 2025 financial results after market close on March 4, 2026. The company will host a conference call at 1:30 PM PT / 4:30 PM ET the same day and provide a live and archived webcast.

Investors may register to participate in the conference call and access the webcast on BillionToOne's investor relations "Events" page.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.
Argus Feb 17 session
+5.16% close to close Open Argus
Details

News Market Reaction – BLLN

On Feb 17, the day this news came out, BLLN closed 5.16% above the previous close.

Data tracked by StockTitan Argus for the Feb 17 session.

Market Context

On Feb 17, the day this news came out, the stock closed 5.2% above the previous close. A strong posi...
Analysis

On Feb 17, the day this news came out, the stock closed 5.2% above the previous close. A strong positive reaction aligns with how BLLN previously responded to earnings-date announcements, where the prior event saw a +1.66% move. Traders could have treated the scheduled Q4 and full-year 2025 release on March 4, 2026 as a focal point following earlier guidance calling for $415M–$430M in 2026 revenue. However, such calendar notices alone offer limited new information, so enthusiasm might fade without supportive reported results.

Key Figures

2025 revenue guidance: $293M–$299M 2026 revenue guidance: $415M–$430M Guided revenue growth: 40%–45% +5 more
2025 revenue guidance
$293M–$299M
Full-year 2025 guidance reiterated on Jan 12, 2026
2026 revenue guidance
$415M–$430M
Full-year 2026 guidance initiated on Jan 12, 2026
Guided revenue growth
40%–45%
Implied 2026 growth vs. midpoint of 2025 guidance
Major holder stake
19.6%
Hummingbird-affiliated ownership of Class A common stock (Schedule 13D)
Hummingbird purchase price
$93,673,956.50
Total cost of preferred and common shares reported in Schedule 13D
NeoTribe ownership
10.6%
Aggregate beneficial ownership of Class A common stock (Schedule 13G)
CFO option grant
175,000 shares at $11.55
Stock options vesting over four years from Jan 8, 2025
CFO option grant
75,000 shares at $30.78
Stock options vesting over four years from Sep 15, 2025

Previous Earnings date Reports

1 past event · Latest: Dec 02
Same Type 1 event
  1. Dec 02

    Earnings date notice

    24h Move
    +1.7%

    Set Q3 2025 earnings release date and conference call details.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

MENLO PARK, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that the Company plans to release its financial results for fourth quarter and full year ended December 31, 2025 after the market close on Wednesday, March 4, 2026. BillionToOne will host a conference call to discuss its financial results at 1:30pm Pacific Time / 4:30pm Eastern Time the same day.

To participate in the conference call, please register here before the 1:30pm Pacific Time / 4:30pm Eastern Time start. A live and archived webcast will be available on the “Events” page of BillionToOne’s investor relations website at https://investors.billiontoone.com/.

About BillionToOne

Headquartered in Menlo Park, California, BillionToOne is a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all. The company's patented Quantitative Counting Templates™ (QCT™) molecular counting platform is the only multiplex technology that can accurately count DNA molecules at the single-molecule level. For more information, visit www.billiontoone.com.

Investor Contact
ir@billiontoone.com

Media Contact
billiontoone@moxiegrouppr.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will BillionToOne (BLLN) report Q4 and full year 2025 results?

BillionToOne will release Q4 and full year 2025 results after market close on March 4, 2026. According to BillionToOne, the announcement will be followed by a conference call at 1:30 PM PT / 4:30 PM ET the same day with a live webcast.

What time is the BillionToOne (BLLN) earnings conference call on March 4, 2026?

The conference call is scheduled for 1:30 PM Pacific Time / 4:30 PM Eastern Time on March 4, 2026. According to BillionToOne, investors must register ahead of the start to participate and a webcast will be available on the Events page.

How can investors join the BillionToOne (BLLN) March 4, 2026 webcast and call?

Investors can register to join the conference call and access the live webcast via BillionToOne's investor relations Events page. According to BillionToOne, an archived webcast will also be available after the live presentation for later viewing.

Will BillionToOne (BLLN) provide a replay of the March 4, 2026 earnings webcast?

Yes, BillionToOne will provide an archived webcast of the March 4, 2026 event on its investor relations Events page. According to BillionToOne, the replay will be available after the live conference call concludes.

Where is the BillionToOne (BLLN) investor webcast hosted for the March 4, 2026 results?

The webcast is hosted on BillionToOne's investor relations website Events page at https://investors.billiontoone.com/. According to BillionToOne, both the live webcast and archived replay will be available there for registered investors and the public.

Keep reading